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This Month in the Journal
This month in the Journal, Eleanor Feingold (p. 217)
discusses regression-based QTL mapping. Because it can
be overwhelming to consider the different methods
out there, Dr. Feingold attempts to simplify this choice
through comparisons of the different statistics, in terms
of power and robustness, as well as their individual
strengths and weaknesses. Dr. Feingold also explains how
the new regression-based method developed by Sham et
al. (p. 238), which can handle pedigrees of arbitrary struc-
ture, might be a useful alternative.
Stratification in Association Studies, by Ardlie et al.
(p. 304)
Difficulties in replicating disease-marker associationshave
often been blamed on population structure, something
that has been feared to give spurious results in association
studies in general. Using four real case-control cohorts,
Ardlie et al. report that, at least in a well-matched, mod-
erately sized sample, population stratification is probably
not as big a problem as has been feared. The samples
examined were U.S. whites and African Americans with
hypertension and U.S. whites and Polish whites with type
2 diabetes, all with appropriate controls. Ardlie et al.
found no evidence of significant population structure,
which is detected as an overall difference in marker-allele
frequencies between groups, except in the African Amer-
ican sample. The stratification among African Americans
was no longer seen if recent immigrants were removed
from consideration, thereby removing some of the sample
heterogeneity. Despite the lack of detectable population
stratification, an attempt to replicate an association be-
tween the PPARg Pro12Ala polymorphism and type 2
diabetes still gave discrepant results between the U.S. and
Polish populations. Part of the explanation for this dis-
crepancy may be the difference in power between the
samples (which are the same size), due to a difference in
the frequency of the risk allele between the two popula-
tions. Although this work is encouraging for investigators
who use heterogeneous populations in association studies,
it is clear that researchers need to be aware of factors,
other than population stratification, that may affect the
outcome of association studies.
Human Long Interspersed Elements, by Myers et al.
(p. 312)
A recently integrated subfamily of L1 long interspersed
elements can be distinguished on the basis of a shared
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sequence within the 3′ untranslated region. Myers et al.
use this sequence to extract all members of this L1 sub-
family from the human genome sequence, yielding 468
hits. All but one of these sequences are absent from the
orthologous position in nonhuman primates, indicating
that they inserted after the divergence of humans andapes.
Although a little more than half of these L1 elements were
fixed present (meaning that every tested individual was
homozygous for the presence of the element), the restwere
polymorphic and were present at widely different fre-
quencies. Some of the polymorphic insertions are popu-
lation specific, their frequencies differing by at least 25%
between populations. These insertions may prove to be
useful markers in future population-genetics studies, be-
cause they represent unique events; all individuals pos-
sessing a particular L1 element inherited it identical by
descent. Furthermore, the ancestral allele is known—it is
the absence of the insertion—and this makes it easier to
determine the root of phylogenetic trees.
Association between Dysbindin and Schizophrenia, by
Straub et al. (p. 337)
Straub et al. report that variation in the gene for dysbin-
din, DTNBP1, is associated with schizophrenia. In a pre-
vious study by the same group (see the reference cited by
Straub et al.), a genomewide scan, usingmultiplex families
with schizophrenia, identified two linkage peaks on chro-
mosome 6, one at 6p24 and one at 6p22. In the current
report, the authors further investigate the 6p22 region,
using SNPs and simple-sequence length polymorphisms.
Markers and marker haplotypes in this region show
an association with schizophrenia, and, because the
markers with positive results are largely clustered within
DTNBP1, this may be the gene underlying the associ-
ation. Dysbindin is likely to be a component of the dys-
trophin protein complex, which is found in postsynaptic
densities in the brain. This complex is thought to be
involved in neuromuscular synapse formation and syn-
aptic signaling. Although, as the authors state, models
for the role of dysbindin in schizophrenia are entirely
speculative, it is interesting to note that neuropatholog-
ical evidence shows that there are synaptic changes as-
sociated with schizophrenia.
Pericentric Inversion Breakpoints of PTR19, by
Kehrer-Sawatzki et al. (p. 375)
Although, on a DNA-sequence level, humans and chim-
panzees show only ∼1% average sequence divergence,
some obvious differences can be observed between cer-
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tain human and chimpanzee chromosomes. These in-
clude a chromosome fusion and a few pericentric in-
versions. Although these differences could provide us
with a better understanding of human-chimpanzee dif-
ferences and the evolution of Homo sapiens, they have
gone largely uncharacterized. Kehrer-Sawatzki et al. have
investigated the pericentric inversion by which chim-
panzee chromosome 19 differs from human chromo-
some 17. The authors cloned and characterized the
breakpoints and found that they occurred in regions rich
with repetitive elements. A repeat-mediated, nonhom-
ologous recombination method is proposed for this in-
version. No gene disruption or obvious difference in gene
expression was observed between the species, so the di-
rect effects of this inversion are unclear.
A CHEK2 Variant in Familial Breast Cancer, by
Vahteristo et al. (p. 432)
Vahteristo et al. have provided the first confirmation, in
two independent samples, of the recently published as-
sociation between the CHEK2 1100delC mutation and
breast cancer [CHEK2 Breast Cancer Consortium (2002)
Nat Genet 31:55–59]. This inactivating mutation was
originally identified in individuals with Li-Fraumeni syn-
drome, a cancer-susceptibility syndrome that often in-
cludes breast cancer, and this finding led researchers to
determine whether CHEK2 might be involved in non-
syndromic forms of breast cancer. As in the article by
the CHEK2 Breast Cancer Consortium, theCHEK2 var-
iant was not found at a significantly higher frequency
in a population-based series of individuals with breast
cancer than in control individuals. However, when co-
horts were selected for a positive family history of breast
cancer and a lack of BRCA1 and BRCA2 mutations,
the frequency of the CHEK2 variant was increased, even
when the case patients had only one affected first-degree
relative. The frequency of the CHEK2 mutation was
even higher in a group of individuals with bilateral breast
cancer. CHEK2 1100delC appears to be a relatively
common, low-penetrance allele that may make a signif-
icant contribution to familial clustering of breast cancer
on a population level, but, as yet, mutation screening
for this variant on an individual level will not be useful.
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